Recent News

• 08.20.2025 - The Silent Threat in Cell Therapy Development: Transient Warming Events
• 08.07.2025 - BioLife Solutions Reports Second Quarter 2025 Financial Results
• 07.28.2025 - BioLife Solutions Makes Strategic Investment in Pluristyx
• 07.24.2025 - BioLife Solutions to Report Second Quarter 2025 Financial Results and Business Update on August 7, 2025
• 07.11.2025 - The Cell Summit ’25 Frequently Asked Questions (FAQs)

Recent Filings

• 08.15.2025 - 144 Report of proposed sale of securities
• 08.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.13.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 08.11.2025 - 144 Report of proposed sale of securities
• 08.07.2025 - EX-99.1 EX-99.1
• 08.07.2025 - 8-K Current report
• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.09.2025 - 4 Statement of changes in beneficial ownership of securities